1. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review
   Mingjie Yao et al, 2018, Clinical Reviews in Allergy & Immunology CrossRef
2. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma
   Bin Yu et al, 2019, Digestive Diseases and Sciences CrossRef
3. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
   Tianhui Liu et al, 2017, Oncotarget CrossRef
4. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum
   Xiangyi Liu et al, 2015, Clinica Chimica Acta CrossRef
5. Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patients
   Mohamed M. Makhlouf et al, 2017, The Egyptian Journal of Internal Medicine CrossRef
6. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma
   Bin Yu et al, 2019, Pathology - Research and Practice CrossRef
7. The Predictive Value of Golgi Protein 73 in Differentiating Benign from Malignant Liver Tumors
   Mirelle E. E. Bröker et al, 2014, PLoS ONE CrossRef
8. Effect of sample type and storage conditions on Golgi membrane protein 73 stability
   Marwa M. Esawy et al, 2019, Scandinavian Journal of Clinical and Laboratory Investigation CrossRef
9. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance
   Manar M. Ismail et al, 2017, Scandinavian Journal of Clinical and Laboratory Investigation CrossRef
10. Glycosylation Change of alpha-1-acid Glycoprotein as a Serum Biomarker for Hepatocellular Carcinoma and Cirrhosis
    Delin Zhang et al, 2017, Biomarkers in Medicine CrossRef
11. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis
    Yuming Zhang et al, 2016, Journal of Immunoassay and Immunochemistry CrossRef
12. Preparation and Characterization of Anti-GP73 Monoclonal Antibodies and Development of Double-antibody Sandwich ELISA
    Qi-Wen Li et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
13. Golgi protein 73 and its diagnostic value in liver diseases
    Yanyan Xia et al, 2019, Cell Proliferation CrossRef
14. Possible roles of Golgi protein-73 in liver diseases
    Meng-Yuan Liu et al, 2022, Annals of Hepatology CrossRef
15. Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis
    JING YANG et al, 2015, Experimental and Therapeutic Medicine CrossRef
16. Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
    Leijie Wang et al, 2020, Disease Markers CrossRef
17. Serum biomarkers and ultrasensitive biosensors for diagnosis of early-stage hepatocellular carcinoma
    Lorico DS. Lapitan et al, 2023, Sensors and Actuators B: Chemical CrossRef
18. Golgi protein 73, hepatocellular carcinoma and other types of cancers
    Yanan Wang et al, 2020, Liver Research CrossRef
19. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
    Meiyu Dai et al, 2015, PLOS ONE CrossRef
20. Targeting Gene-Virus-Mediated Manganese Superoxide Dismutase Effectively Suppresses Tumor Growth in Hepatocellular Carcinoma In Vitro and In Vivo
    Fang Huang et al, 2014, Cancer Biotherapy and Radiopharmaceuticals CrossRef
21. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels
    Wan-Ju Xu et al, 2014, Tumor Biology CrossRef
22. Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinoma
    Jufeng Xia et al, 2016, Drug Discoveries & Therapeutics CrossRef
23. A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions
    Yang Ma et al, 2024, Frontiers in Medicine CrossRef
24. Application and progress of the detection technologies in hepatocellular carcinoma
    Qi Yan et al, 2023, Genes & Diseases CrossRef